4.7 Article

T cell-derived interleukin (IL)-21 promotes brain injury following stroke in mice

Journal

JOURNAL OF EXPERIMENTAL MEDICINE
Volume 211, Issue 4, Pages 595-604

Publisher

ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20131377

Keywords

-

Funding

  1. American Heart Association [12PRE12060020]
  2. National Institutes of Health [NS037570, NS076946, AI048087, AI068730]

Ask authors/readers for more resources

T lymphocytes are key contributors to the acute phase of cerebral ischemia reperfusion injury, but the relevant T cell-derived mediators of tissue injury remain unknown. Using a mouse model of transient focal brain ischemia, we report that IL-21 is highly up-regulated in the injured mouse brain after cerebral ischemia. IL-21-deficient mice have smaller infarcts, improved neurological function, and reduced lymphocyte accumulation in the brain within 24 h of reperfusion. Intracellular cytokine staining and adoptive transfer experiments revealed that brain-infiltrating CD4(+) T cells are the predominant IL-21 source. Mice treated with decoy IL-21 receptor Fc fusion protein are protected from reperfusion injury. In postmortem human brain tissue, IL-21 localized to perivascular CD4(+) T cells in the area surrounding acute stroke lesions, suggesting that IL-21-mediated brain injury may be relevant to human stroke.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available